Factors associated with biochemical remission after microscopic transsphenoidal surgery for acromegaly

Journal of Neurological Surgery, Part B: Skull Base

Volumn 75, Issue 1, 2014, Pages 47-52

  Sun, Hai ^a   Brzana, Jessica ^b   Yedinak, Chris G ^a   Gultekin, Sakir H ^b   Delashaw, Johnny B ^c   Fleseriu, Maria ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

acromegaly; remission; transsphenoidal surgery

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR 2;

ACROMEGALY; ADULT; AGED; ARTICLE; CANCER MORPHOLOGY; CANCER REGRESSION; CANCER SURGERY; CHEMICAL ANALYSIS; DEMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENDOCRINE BONE DISEASE; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; MICROSCOPIC TRANSSPHENOIDAL SURGERY; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SURGICAL MICROSCOPE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TUMOR RECURRENCE; YOUNG ADULT;

EID: 84893815913     PISSN: 2193634X     EISSN: 21936331     Source Type: Journal    
DOI: 10.1055/s-0033-1354578     Document Type: Article

References (37)

1. Baris D., Gridley G., Ron E., et al. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control: 2002; 13 5 395 400 (Pubitemid 34666594)
2. Bynke O., Karlberg B. E., Kågedal B., Nilsson O. R. Early post-operative growth hormone levels predict the result of transsphenoidal tumour removal in acromegaly. Acta Endocrinol (Copenh): 1983; 103 2 158 162 (Pubitemid 13093813)
3. Melmed S. Medical progress: acromegaly. N Engl J Med: 2006; 355 24 2558 2573
4. Rajasoorya C., Holdaway I. M., Wrightson P., Scott D. J., Ibbertson H. K. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf): 1994; 41 1 95 102 (Pubitemid 24232533)
5. Webb S. M., Casanueva F., Wass J. A. Oncological complications of excess GH in acromegaly. Pituitary: 2002; 5 1 21 25 (Pubitemid 36267050)
6. Beauregard C., Truong U., Hardy J., Serri O. Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf): 2003; 58 1 86 91 (Pubitemid 36098853)
7. Campbell P. G., Kenning E., Andrews D. W., Yadla S., Rosen M., Evans J. J. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas. Neurosurg Focus: 2010; 29 4 E5
8. Cappabianca P., Cavallo L. M., Colao A., et al. Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg: 2002; 45 4 193 200 (Pubitemid 36098186)
9. Cook D. M., Ezzat S., Katznelson L., et al. AACE Acromegaly Guidelines Task Force. AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly. Endocr Pract: 2004; 10 3 213 225
10. De P., Rees D. A., Davies N., et al. Transsphenoidal surgery for acromegaly in Wales: results based on stringent criteria of remission. J Clin Endocrinol Metab: 2003; 88 8 3567 3572 (Pubitemid 37034496)
11. Dehdashti A. R., Ganna A., Karabatsou K., Gentili F. Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery: 2008; 62 5 1006 1015; discussion 1015-1017
12. Freda P. U., Nuruzzaman A. T., Reyes C. M., Sundeen R. E., Post K. D. Significance of abnormal nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab: 2004; 89 2 495 500 (Pubitemid 38269847)
13. Jane J. A. Jr, Starke R. M., Elzoghby M. A., et al. Endoscopic transsphenoidal surgery for acromegaly: remission using modern criteria, complications, and predictors of outcome. J Clin Endocrinol Metab: 2011; 96 9 2732 2740
14. Ludecke D. K., Abe T. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations. Neuroendocrinology: 2006; 83 3-4 230 239 (Pubitemid 44578877)
15. Nomikos P., Buchfelder M., Fahlbusch R. The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure.'. Eur J Endocrinol: 2005; 152 3 379 387 (Pubitemid 40439490)
16. Shimon I., Cohen Z. R., Ram Z., Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery: 2001; 48 6 1239 1243; discussion 1244-1245
17. Yano S., Kawano T., Kudo M., et al. Endoscopic endonasal transsphenoidal approach through the bilateral nostrils for pituitary adenomas. Neurol Med Chir (Tokyo): 2009; 49 1 1 7
18. Giustina A., Barkan A., Casanueva F. F., et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab: 2000; 85 2 526 529 (Pubitemid 32273628)
19. Giustina A., Chanson P., Bronstein M. D., et al. Acromegaly Consensus Group. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab: 2010; 95 7 3141 3148
20. Arafat A. M., Möhlig M., Weickert M. O., et al. Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index. J Clin Endocrinol Metab: 2008; 93 4 1254 1262 (Pubitemid 351519718)
21. Fleseriu M., Delashaw J. B. Jr, Cook D. M. Acromegaly: a review of current medical therapy and new drugs on the horizon. Neurosurg Focus: 2010; 29 4 E15
22. Brzana J., Yedinak C. G., Gultekin S. H., Delashaw J. B., Fleseriu M. Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience. Pituitary: 2012
23. Fougner S. L., Casar-Borota O., Heck A., Berg J. P., Bollerslev J. Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly. Clin Endocrinol (Oxf): 2012; 76 1 96 102
24. Kato M., Inoshita N., Sugiyama T., et al. Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas. Endocr J: 2012; 59 3 221 228
25. Lopes M. B. Growth hormone-secreting adenomas: pathology and cell biology. Neurosurg Focus: 2010; 29 4 E2
26. Osamura R. Y., Kajiya H., Takei M., et al. Pathology of the human pituitary adenomas. Histochem Cell Biol: 2008; 130 3 495 507
27. Lee E. J., Ahn J. Y., Noh T., Kim S. H., Kim T. S., Kim S. H. Tumor tissue identification in the pseudocapsule of pituitary adenoma: should the pseudocapsule be removed for total resection of pituitary adenoma? Neurosurgery: 2009; 64 (3, Suppl): ons62 ons69; discussion ons69-ons70
28. Knosp E., Steiner E., Kitz K., Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery: 1993; 33 4 610 617; discussion 617-618
29. Remmele W., Stegner H. E. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue [in German]. Pathologe: 1987; 8 3 138 140
30. Frank G., Pasquini E. Endoscopic endonasal cavernous sinus surgery, with special reference to pituitary adenomas. Front Horm Res: 2006; 34 64 82 (Pubitemid 43265654)
31. Gondim J. A., Almeida J. P., de Albuquerque L. A., Gomes E., Schops M., Ferraz T. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center. Neurosurg Focus: 2010; 29 4 E7
32. Hofstetter C. P., Mannaa R. H., Mubita L., et al. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. Neurosurg Focus: 2010; 29 4 E6
33. Kabil M. S., Eby J. B., Shahinian H. K. Fully endoscopic endonasal vs. transseptal transsphenoidal pituitary surgery. Minim Invasive Neurosurg: 2005; 48 6 348 354 (Pubitemid 43219011)
34. Rudnik A., Zawadzki T., Wojtacha M., et al. Endoscopic transnasal transsphenoidal treatment of pathology of the sellar region. Minim Invasive Neurosurg: 2005; 48 2 101 107 (Pubitemid 40769556)
35. Tabaee A., Anand V. K., Barrón Y., et al. Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg: 2009; 111 3 545 554
36. Wilson T. J., McKean E. L., Barkan A. L., Chandler W. F., Sullivan S. E. Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications. Pituitary: 2013
37. Nishioka H., Haraoka J. Biochemical cure of acromegaly after transsphenoidal surgery despite residual tumor on magnetic resonance imaging: case report. Neurol Med Chir (Tokyo): 2008; 48 7 311 313